Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × enfortumab vedotin × Clear all

NCT07157956 2025-09-05

CVL006-T1002

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor